DRUG: Acalabrutinib
BIOLOGICAL: Obinutuzumab
BIOLOGICAL: JCAR017 (lisocabtagene maraleucel)
BIOLOGICAL: JCAR017 (lisocabtagene maraleucel) + ibrutinib
BIOLOGICAL: JCAR017 (lisocabtagene maraleucel) + venetoclax
BIOLOGICAL: Peripheral Blood Stem Cell Transplant
DRUG: Allopurinol 300 MG
DRUG: Fludarabine
DRUG: Cyclophosphamide
BIOLOGICAL: Bone Marrow Cell Transplant
RADIATION: Total Body Irradiation
DRUG: Sirolimus Pill
DRUG: Mycophenolate Mofetil
DRUG: AVM0703
BIOLOGICAL: CD19/CD22 CAR T-Cells
DRUG: Fludarabine
DRUG: Cyclophosphamide
BIOLOGICAL: Zilovertamab vedotin
DRUG: Nemtabrutinib
DRUG: Pirtobrutinib
DRUG: Venetoclax
DRUG: Rituximab
DRUG: Nemtabrutinib
PROCEDURE: Hematopoietic Cell Transplantation
DRUG: Mycophenolate Mofetil
DRUG: Tacrolimus
DRUG: Cyclophosphamide
RADIATION: Total-Body Irradiation
PROCEDURE: Donor Lymphocyte Infusion
DRUG: Fludarabine
DRUG: Melphalan
DRUG: Nicotinamide
DRUG: Placebo
DRUG: Zanubrutinib
DRUG: Obinutuzumab
DRUG: Venetoclax
BIOLOGICAL: Anti-CD19/CD20/CD22 CAR T-Cells
DRUG: Cyclophosphamide
DRUG: Fludarabine Phosphate
DRUG: Busulfan
DRUG: Busulfan
DRUG: Fludarabine
RADIATION: Total-body irradiation
DRUG: Cyclophosphamide
DRUG: Melphalan
PROCEDURE: PBSC Hematopoietic Stem Cell Transplantation (HSCT)
PROCEDURE: Bone Marrow Hematopoietic Stem Cell Transplantation
DRUG: Post-transplant Cyclophosphamide
DRUG: Mesna
DRUG: Tacrolimus
DRUG: Mycophenolate Mofetil
OTHER: Patient-Reported Outcomes
BIOLOGICAL: NKX019
DRUG: ABBV-525
DIETARY_SUPPLEMENT: Cholecalciferol
OTHER: Laboratory Biomarker Analysis
PROCEDURE: Allogeneic Hematopoietic Stem Cell Transplantation
DRUG: Cyclophosphamide
DRUG: Cyclosporine
BIOLOGICAL: Filgrastim
DRUG: Fludarabine
DRUG: Mycophenolate Mofetil
DRUG: Mycophenolate Sodium
RADIATION: Total-Body Irradiation
DRUG: Treosulfan
PROCEDURE: Bone Marrow Aspiration
PROCEDURE: Bone Marrow Biopsy
PROCEDURE: Echocardiography
PROCEDURE: Biospecimen Collection
PROCEDURE: Computed Tomography
PROCEDURE: Positron Emission Tomography
BIOLOGICAL: Autologous Anti-CD19 CAR-expressing T-lymphocytes IC19/1563
DRUG: Bendamustine
PROCEDURE: Biospecimen Collection
PROCEDURE: Bone Marrow Aspiration
PROCEDURE: Bone Marrow Biopsy
PROCEDURE: Computed Tomography
DRUG: Cyclophosphamide
DRUG: Fludarabine
PROCEDURE: Magnetic Resonance Imaging
PROCEDURE: Positron Emission Tomography
DRUG: Loncastuximab Tesirine and Acalabrutinib
RADIATION: Total-Body Irradiation
DRUG: Thiotepa
DRUG: Fludarabine
DRUG: Cyclophosphamide
DRUG: Busulfan
PROCEDURE: Allogeneic Bone Marrow Transplantation
DRUG: Tacrolimus
DRUG: Methotrexate
PROCEDURE: Naive T Cell-Depleted Hematopoietic Stem Cell Transplantation
PROCEDURE: Biopsy
PROCEDURE: Biospecimen Collection
PROCEDURE: Computed Tomography
BIOLOGICAL: Loncastuximab Tesirine
BIOLOGICAL: Mosunetuzumab
PROCEDURE: Positron Emission Tomography
GENETIC: KUR-502
BIOLOGICAL: Fully human anti CD19 CAR-T Cell Dose
DRUG: Fludarabine
DRUG: Cyclophosphamide
DRUG: Cyclophosphamide injection
DRUG: Fludarabine Injection
BIOLOGICAL: CD19-CD34t metabolically programmed CAR transduced T-cells
DRUG: Nemtabrutinib
DRUG: Venetoclax
BIOLOGICAL: Rituximab
BIOLOGICAL: Pneumococcal 20-valent Conjugate Vaccine
BIOLOGICAL: Pneumococcal Polyvalent Vaccine
OTHER: Questionnaire Administration
DRUG: Conditioning Chemotherapy
BIOLOGICAL: Cord blood graft
DRUG: Nemtabrutinib
DRUG: Fludarabine
DRUG: Cyclophosphamide
DRUG: Bendamustine
BIOLOGICAL: Rituximab
BIOLOGICAL: Truxima
BIOLOGICAL: Ruxience
BIOLOGICAL: Riabni
GENETIC: CD19.CAR-aNKT cells
DRUG: Busulfan
DRUG: Fludarabine
PROCEDURE: PBSC Hematopoietic Stem Cell Transplantation (HSCT)
DRUG: Post-Transplant Cyclophosphamide
DRUG: Mesna
DRUG: Tacrolimus
DRUG: Mycophenolate Mofetil
OTHER: Patient Reported Outcomes
DRUG: Melphalan
RADIATION: Total-body irradiation
DRUG: Cyclophosphamide
DRUG: APG2575
DRUG: Zanubrutinib
BIOLOGICAL: Anti-Thymocyte Globulin
DRUG: Cyclophosphamide
BIOLOGICAL: Cytokine-treated Veto Cells
DRUG: Fludarabine
PROCEDURE: Peripheral Blood Stem Cell Transplantation
RADIATION: Total-Body Irradiation
DRUG: Xembify
DRUG: Placebo
DRUG: NX-2127
BIOLOGICAL: CD19/CD22-CAR-transduced T cells
DRUG: cyclophosphamide
DRUG: fludarabine
DRUG: Acalabrutinib
BIOLOGICAL: Obinutuzumab
DRUG: Venetoclax
DRUG: Anti-thymocyte globulin (rabbit)
DRUG: Blinatumomab
DRUG: Cyclophosphamide
DRUG: Fludarabine
DRUG: G-CSF
DRUG: Melphalan
DRUG: Mesna
DRUG: Rituximab
DRUG: Tacrolimus
DRUG: Thiotepa
BIOLOGICAL: HPC,A Infusion
DEVICE: CliniMACS
DRUG: Sirolimus
DRUG: voruciclib monotherapy
DRUG: voruciclib and venetoclax
DRUG: RP-3500 in combination with Olaparib
DRUG: Chimeric Antigen Receptor (CAR) T-Cell Product (Autologous)
BIOLOGICAL: Autologous BAFFR-targeting CAR T Cells
DRUG: Bendamustine
PROCEDURE: Biopsy
PROCEDURE: Biospecimen Collection
PROCEDURE: Bone Marrow Aspiration and Biopsy
PROCEDURE: Computed Tomography
DRUG: Cyclophosphamide
PROCEDURE: Echocardiography
DRUG: Fludarabine
PROCEDURE: Leukapheresis
PROCEDURE: Magnetic Resonance Imaging
PROCEDURE: Positron Emission Tomography
DRUG: Venetoclax
DRUG: cBTKi Monotherapy
PROCEDURE: Haploidentical Bone Marrow/Kidney
GENETIC: Dose Escalation Phase:CD19.CAR/28 and CD19.CAR/28137 T cells
GENETIC: Expansion Phase: CD19.CAR/28 and CD19.CAR/28137 T cells
BIOLOGICAL: Kappa CD28 T cells
BIOLOGICAL: Dilanubicel
DRUG: Cyclophosphamide
DRUG: Fludarabine
DRUG: Thiotepa
RADIATION: Total-Body Irradiation
PROCEDURE: Umbilical Cord Blood Transplantation
OTHER: Laboratory Biomarker Analysis
PROCEDURE: Biospecimen Collection
PROCEDURE: Bone Marrow Aspirate
PROCEDURE: Bone Marrow Biopsy
PROCEDURE: Multigated Acquisition Scan
PROCEDURE: Electrocardiography
PROCEDURE: Computed Tomography
DRUG: ABL001
DRUG: Dasatinib
DRUG: Prednisone
DRUG: Blinatumomab
DRUG: Nemtabrutinib
DRUG: Ibrutinib
DRUG: Acalabrutinib
PROCEDURE: Biopsy
PROCEDURE: Biospecimen Collection
PROCEDURE: Bone Marrow Biopsy
PROCEDURE: Computed Tomography
DRUG: Cyclophosphamide
DRUG: Fludarabine
DRUG: Ibrutinib
BIOLOGICAL: Lisocabtagene Maraleucel
BIOLOGICAL: Nivolumab
PROCEDURE: Pheresis
PROCEDURE: Positron Emission Tomography
DRUG: Fludarabine
DRUG: Cyclophosphamide
BIOLOGICAL: PRGN-3007
DRUG: CAP-100
DRUG: ABBV-319
DEVICE: CliniMACS
BIOLOGICAL: Allogeneic Natural Killer Cell Line NK-92
BIOLOGICAL: Anti-Thymocyte Globulin
DRUG: Busulfan
DRUG: Clofarabine
DRUG: Cyclophosphamide
DRUG: Fludarabine Phosphate
OTHER: Laboratory Biomarker Analysis
DRUG: Melphalan
BIOLOGICAL: Rituximab
RADIATION: Total-Body Irradiation
PROCEDURE: Umbilical Cord Blood Transplantation
GENETIC: Autologous TRICAR-ALL T-cells and lymphodepletion chemotherapy
DRUG: Sonrotoclax
DRUG: Zanubrutinib
DRUG: Venetoclax
DRUG: Obinutuzumab
PROCEDURE: Biospecimen Collection
PROCEDURE: Bone Marrow Aspiration
PROCEDURE: Bone Marrow Biopsy
PROCEDURE: Computed Tomography
BIOLOGICAL: Obinutuzumab
OTHER: Quality-of-Life Assessment
OTHER: Questionnaire Administration
DRUG: Venetoclax
DRUG: SC291
DRUG: Iopofosine I 131 single dose
DRUG: Iopofosine I 131 multiple dose
DRUG: Iopofosine I 131 fractionated dose
DRUG: Ibrutinib
DRUG: Venetoclax
DRUG: Acalabrutinib
BIOLOGICAL: CART22 cells transduced with a lentiviral vector to express anti-CD22 scFv TCRz:41BB
DRUG: BGB-16673
BIOLOGICAL: CTX112
PROCEDURE: Biospecimen Collection
PROCEDURE: Bone Marrow Aspirate
DRUG: Cyclophosphamide
DRUG: Cyclosporine
PROCEDURE: Diagnostic Imaging
PROCEDURE: Echocardiography
DRUG: Fludarabine Phosphate
PROCEDURE: Multigated Acquisition Scan
DRUG: Mycophenolate Mofetil
OTHER: Survey Administration
DRUG: Thiotepa
RADIATION: Total-Body Irradiation
PROCEDURE: Umbilical Cord Blood Transplantation
DRUG: Zanubrutinib Pill
DRUG: Venetoclax Pill
DRUG: Obinutuzumab Injection
DRUG: Atezolizumab
OTHER: Laboratory Biomarker Analysis
BIOLOGICAL: Obinutuzumab
DRUG: Venetoclax
BIOLOGICAL: OrcaGraft (Orca-Q)
BIOLOGICAL: Autologous HuCD19 ( Anti-CD19)CAR T cells
DRUG: Cyclophosphamide
DRUG: Fludarabine
DRUG: Rituximab
DRUG: NeoVax
DRUG: Cyclophosphamide
DRUG: Pembrolizumab
DRUG: Ibrutinib
DRUG: Pembrolizumab
GENETIC: ALLO-501A
BIOLOGICAL: ALLO-647
DRUG: Fludarabine
DRUG: Cyclophosphamide
DRUG: Venetoclax
DRUG: Acalabrutinib
DRUG: Obinutuzumab
DRUG: Acalabrutinib
BIOLOGICAL: Durvalumab
DRUG: Venetoclax
DRUG: Pirtobrutinib
DRUG: Venetoclax
DRUG: Pirtobrutinib
DRUG: Obinutuzumab
DRUG: Venetoclax
DRUG: Valacyclovir
DRUG: Allopurinol
DRUG: Fludarabine
DRUG: Cyclophosphamide
RADIATION: Total Body Irradiation
DRUG: Cyclosporine A
DRUG: Mycophenylate mofetil
BIOLOGICAL: Umbilical cord blood
DRUG: ONO-7018
DRUG: ONO-7018
DRUG: Venetoclax
DRUG: Obinutuzumab
DRUG: ABBV-101
BIOLOGICAL: Rituximab
DRUG: Zanubrutinib
DEVICE: Miltenyi CliniMACS Prodigy ® system
PROCEDURE: Biospecimen Collection
PROCEDURE: Bone Marrow Biopsy
PROCEDURE: Computed Tomography
DRUG: Cyclophosphamide
DRUG: Fludarabine
PROCEDURE: Leukapheresis
BIOLOGICAL: Lisocabtagene Maraleucel
PROCEDURE: Lymph Node Biopsy
PROCEDURE: Positron Emission Tomography
DRUG: Zanubrutinib
DRUG: Venetoclax
DRUG: Obinutuzumab
DRUG: Rituximab
BIOLOGICAL: Rapcabtagene autoleucel single agent
DRUG: Ibrutinib
DRUG: Acalabrutinib
OTHER: Laboratory Biomarker Analysis
BIOLOGICAL: Obinutuzumab
OTHER: Patient Observation
OTHER: Quality-of-Life Assessment
BIOLOGICAL: Epcoritamab
BIOLOGICAL: Epcoritamab
DRUG: rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone
DRUG: Venetoclax
BIOLOGICAL: Epcoritamab
DRUG: Lenalidomide
PROCEDURE: Biospecimen Collection
PROCEDURE: Bone Marrow Aspiration
PROCEDURE: Bone Marrow Biopsy
PROCEDURE: Computed Tomography
PROCEDURE: Magnetic Resonance Imaging
DRUG: Pirtobrutinib
PROCEDURE: Positron Emission Tomography
DRUG: Venetoclax
PROCEDURE: Echocardiography
PROCEDURE: Multigated Acquisition Scan
DRUG: SGR-1505
DRUG: Venetoclax monotherapy
DRUG: Venetoclax with anti CD20 monoclonal antibody
DRUG: AS-1763
DRUG: AC676
DRUG: Mosunetuzumab
DRUG: Tocilizumab
DRUG: Venetoclax
DRUG: L-Bcl-2 antisense oligonucleotide
DRUG: JNJ-80948543
PROCEDURE: Biospecimen Collection
PROCEDURE: Bone Marrow Aspiration
PROCEDURE: Bone Marrow Biopsy
PROCEDURE: Computed Tomography
DRUG: Pirtobrutinib
DRUG: Venetoclax
DRUG: Venetoclax
DRUG: Obinutuzumab
DRUG: Acalabrutinib
DRUG: Acalabrutinib
PROCEDURE: Biospecimen Collection
PROCEDURE: Bone Marrow Aspiration
PROCEDURE: Bone Marrow Biopsy
PROCEDURE: Computed Tomography
PROCEDURE: Echocardiography
BIOLOGICAL: Obinutuzumab
OTHER: Questionnaire Administration
BIOLOGICAL: Tafasitamab
BIOLOGICAL: huCART19-IL18
DRUG: Acalabrutinib
DRUG: Venetoclax
DRUG: EAGD T-cell infusion (Phase I)
DRUG: EAGD T-cell infusion (Expansion)
PROCEDURE: Biospecimen Collection
PROCEDURE: Bone Marrow Biopsy
PROCEDURE: Computed Tomography
BIOLOGICAL: Tafasitamab
DRUG: Zanubrutinib
DRUG: Pirtobrutinib
DRUG: Obinutuzumab
DRUG: Fludarabine
DRUG: Cyclophosphamide
BIOLOGICAL: anti-CD19 CAR-T cells
BIOLOGICAL: Chimeric Antigen Receptor T-Cell Therapy
DRUG: Cyclophosphamide
DRUG: Fludarabine Phosphate
BIOLOGICAL: Tocilizumab
DEVICE: Magnetic-Activated Cell Sorter (CliniMACS, Miltenyi)
PROCEDURE: Allogeneic Hematopoietic Stem Cell Transplantation
PROCEDURE: Biospecimen Collection
DRUG: Granulocyte Colony-Stimulating Factor
DRUG: Hematopoietic Cell Transplantation Conditioning Regimen
BIOLOGICAL: Multi-peptide CMV-Modified Vaccinia Ankara Vaccine
PROCEDURE: Pheresis
DRUG: Placebo Administration
DRUG: Stem Cell Mobilization Therapy
DRUG: LP-118
BIOLOGICAL: Blinatumomab
DRUG: Cytarabine
DRUG: Methotrexate
DRUG: Ponatinib
DRUG: Acalabrutinib
BIOLOGICAL: Obinutuzumab
DRUG: Venetoclax
DRUG: Polatuzumab Vedotin
DRUG: Rituximab
DRUG: Etoposide
DRUG: Prednisone
DRUG: Cyclophosphamide
DRUG: Hydroxydaunomycin
DRUG: DR-01
DRUG: PRT2527
DRUG: Zanubrutinib
DRUG: Venetoclax
DRUG: Ascentage Pharma HQP1351 bioavailable inhibitor
DRUG: Blinatumomab
DRUG: SLS009
DRUG: venetoclax
DRUG: azacitidine
DRUG: Venetoclax
DRUG: Zanubrutinib
DRUG: BMF-219
DRUG: NX-5948
DRUG: Vactosertib
DRUG: Fludarabine Phosphate
DRUG: Cyclophosphamide
DRUG: IL-2
DRUG: Natural Killer Cells
DRUG: MGD024
DRUG: Obinutuzumab
DRUG: ABBV-453
DRUG: Ibrutinib
DRUG: Venetoclax
PROCEDURE: Biopsy
PROCEDURE: Biospecimen Collection
PROCEDURE: Bone Marrow Aspiration
PROCEDURE: Bone Marrow Biopsy
PROCEDURE: Computed Tomography
DRUG: Cyclophosphamide
PROCEDURE: Echocardiography
BIOLOGICAL: EGFRt/19-28z/IL-12 CAR T-lymphocytes
DRUG: Fludarabine Phosphate
PROCEDURE: Leukapheresis
PROCEDURE: Multigated Acquisition Scan
PROCEDURE: Positron Emission Tomography
BIOLOGICAL: HSCT with TBI Regimen
BIOLOGICAL: HSCT with Non-TBI Regimen
DRUG: Glofitamab
DRUG: Obinutuzumab
DRUG: Polatuzumab Vedotin
DRUG: Atezolizumab
DRUG: Tocilizumab
BIOLOGICAL: 8/12-Day Production of Car-T Cells
BIOLOGICAL: 8/12-Day Production of Cryopreserved Car-T Cells
BIOLOGICAL: 12-Day Production of Car-T Cells
DRUG: CAR.k.28
DRUG: Fludarabine
DRUG: Cyclophosphamide
DRUG: Bendamustine
![newsletter icon](https://static.healthtree.org/icons/newsletter-icon.png)
Get the latest thought leadership on your Chronic Lymphocytic Leukemia delivered straight to your inbox
Subscribe to the weekly newsletter for news, stories, clinical trial updates, and helpful resources and events with cancer experts.
Thanks to our HealthTree Community for Chronic Lymphocytic Leukemia Sponsors:
![Abbvie](https://firebasestorage.googleapis.com/v0/b/healthtree-production.appspot.com/o/gallery%2Fpublic%2Fabbvie%20bigger_c5e4f4af-fb3c-45ca-b9f0-831fb4c5f968.jpeg?alt=media)
![Genentech](https://firebasestorage.googleapis.com/v0/b/healthtree-production.appspot.com/o/gallery%2Fpublic%2Fgenentech_b71578d3-7dbe-46d2-9823-4eabf80f387b.png?alt=media)